Comparison of Effectiveness of the Metacognition Treatment and the Mindfulness-based Stress Reduction Treatment on Global and Specific Life Quality of Women with Breast Cancer

Overview

Journal Iran J Cancer Prev

Specialty Oncology

Date 2015 Jan 29

PMID 25628839

Citations 19

Authors

Soheila Rahmani

Siavash Talepasand

ALi Ghanbary-Motlagh

Affiliations

Soon will be listed here.

Abstract

Background: This study is conducted to compare the metacognition treatment and the mindfulness-based stress reduction treatment on life quality of women with breast cancer.

Methods: In a quasi-experimental design, with pre-test, post-test and control group, 36 patients with diagnosis of breast cancer, among patients who referred to the Division of Oncology and Radiotherapy of Imam Hossein hospital in Tehran, were selected in accessible way and were assigned randomly to three experimental groups, the first group receiving meta-cognition treatment (n=12), the second one receiving mindfulness-based stress reduction program (n=12), and the other was the control group. Participants completed global life quality in cancer patient's questionnaire and specific quality of life in breast cancer patient's questionnaire in three stages: baseline, after intervention and two-month follow-up. Data were analyzed using the multivariate repeated measurement model.

Results: Findings showed both treatments were effective in improving global and specific quality of life in patients with breast cancer. The mindfulness -based stress reduction treatment excelled in functions and roles, fatigue, pain, future perspective and treatment side effects symptoms at the end of the treatment and follow-up in comparison to the metacognition treatment.

Conclusion: Results of this research showed the mindfulness-based stress reduction treatment can be effective in improving global and specific life quality of women with breast cancer and is a selective method for improving quality of life in patients.

Citing Articles

Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial.

Lengacher C, Reich R, Rodriguez C, Nguyen A, Park J, Meng H J Integr Complement Med. 2024; 31(1):75-91.

PMID: 39291332 PMC: 11839530. DOI: 10.1089/jicm.2024.0184.

Psychological intervention improves quality of life in patients with early-stage cancer: a systematic review and meta-analysis of randomized clinical trials.

Bognar S, Teutsch B, Veres D, Szabo B, Fogarasi B, Zahariev O Sci Rep. 2024; 14(1):13233.

PMID: 38853187 PMC: 11162999. DOI: 10.1038/s41598-024-63431-y.

Using mindfulness-based stress reduction to relieve loneliness, anxiety, and depression in cancer patients: A systematic review and meta-analysis.

Yu J, Han M, Miao F, Hua D Medicine (Baltimore). 2023; 102(37):e34917.

PMID: 37713902 PMC: 10508374. DOI: 10.1097/MD.0000000000034917.

Effectiveness of Mindfulness-Based Stress Reduction Therapy on the Quality of Life of Patients with Lung Cancer.

Aminnasab A, Hatami M, Ahadi H Tanaffos. 2023; 21(4):503-511.

PMID: 37583782 PMC: 10423868.

Effects of mindfulness-based interventions on fatigue and psychological wellbeing in women with cancer: A systematic review and meta-analysis of randomised control trials.

McCloy K, Hughes C, Dunwoody L, Marley J, Gracey J Psychooncology. 2022; 31(11):1821-1834.

PMID: 36221152 PMC: 9828570. DOI: 10.1002/pon.6046.

References

Roelofs J, Huibers M, Peeters F, Arntz A, van Os J . Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther. 2008; 46(12):1283-9. DOI: 10.1016/j.brat.2008.10.002. View

Hopko D, Bell J, Armento M, Robertson S, Mullane C, Wolf N . Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther. 2008; 39(2):126-36. DOI: 10.1016/j.beth.2007.05.007. View

Wells A, Sembi S . Metacognitive therapy for PTSD: a preliminary investigation of a new brief treatment. J Behav Ther Exp Psychiatry. 2004; 35(4):307-18. DOI: 10.1016/j.jbtep.2004.07.001. View

Lengacher C, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso M, Post-White J . Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2010; 29(2):107-17. DOI: 10.1177/0898010110385938. View

Carmody J, Baer R . Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2007; 31(1):23-33. DOI: 10.1007/s10865-007-9130-7. View

Meeker M, Finnell D, Othman A . Family caregivers and cancer pain management: a review. J Fam Nurs. 2011; 17(1):29-60. DOI: 10.1177/1074840710396091. View

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M . The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Support Care Cancer. 1999; 7(6):400-6. DOI: 10.1007/s005200050300. View

Matousek R, Dobkin P, Pruessner J . Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010; 16(1):13-9. DOI: 10.1016/j.ctcp.2009.06.004. View

Williams J, Duggan D, Crane C, Fennell M . Mindfulness-based cognitive therapy for prevention of recurrence of suicidal behavior. J Clin Psychol. 2005; 62(2):201-10. DOI: 10.1002/jclp.20223. View

10.

Fisher P, Wells A . Metacognitive therapy for obsessive-compulsive disorder: a case series. J Behav Ther Exp Psychiatry. 2007; 39(2):117-32. DOI: 10.1016/j.jbtep.2006.12.001. View

11.

Teasdale J, Segal Z, Williams J, Ridgeway V, Soulsby J, Lau M . Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000; 68(4):615-23. DOI: 10.1037//0022-006x.68.4.615. View

12.

Jacobson N, Dobson K, Truax P, Addis M, Koerner K, Gollan J . A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol. 1996; 64(2):295-304. DOI: 10.1037//0022-006x.64.2.295. View

13.

Carlson L, Speca M, Patel K, Goodey E . Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003; 65(4):571-81. DOI: 10.1097/01.psy.0000074003.35911.41. View

14.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M . The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res. 2000; 9(2):177-84. DOI: 10.1023/a:1008918310251. View

15.

Osborn R, Demoncada A, Feuerstein M . Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006; 36(1):13-34. DOI: 10.2190/EUFN-RV1K-Y3TR-FK0L. View

16.

Micheli A, Coebergh J, Mugno E, Massimiliani E, Sant M, Oberaigner W . European health systems and cancer care. Ann Oncol. 2003; 14 Suppl 5:v41-60. DOI: 10.1093/annonc/mdg753. View

17.

Daughters S, Braun A, Sargeant M, Reynolds E, Hopko D, Blanco C . Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). J Clin Psychiatry. 2008; 69(1):122-9. DOI: 10.4088/jcp.v69n0116. View

18.

Safaee A, Moghim Dehkordi B . Validation study of a quality of life (QOL) questionnaire for use in Iran. Asian Pac J Cancer Prev. 2008; 8(4):543-6. View

19.

Speca M, Carlson L, Goodey E, Angen M . A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000; 62(5):613-22. DOI: 10.1097/00006842-200009000-00004. View

20.

Wells A, Papageorgiou C . Brief cognitive therapy for social phobia: a case series. Behav Res Ther. 2001; 39(6):713-20. DOI: 10.1016/s0005-7967(00)00036-x. View